(19)
(11) EP 4 179 115 A1

(12)

(43) Date of publication:
17.05.2023 Bulletin 2023/20

(21) Application number: 21740093.6

(22) Date of filing: 09.07.2021
(51) International Patent Classification (IPC): 
C12Q 1/6883(2018.01)
G01N 33/50(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6883; C12Q 2600/158; G01N 2800/245
(86) International application number:
PCT/EP2021/069176
(87) International publication number:
WO 2022/008723 (13.01.2022 Gazette 2022/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.07.2020 EP 20382620

(71) Applicants:
  • Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
    08908 Hospitalet de Llobregat, Barcelona (ES)
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Oakland, CA 94607-5200 (US)

(72) Inventors:
  • BESTARD MATAMOROS, Oriol
    08908 L'HOSPITALET DE LLOBREGAT (ES)
  • SARWAL, Minnie
    PORTOLA VALLEY, California 94028 (US)
  • PINEDA SAN JUAN, Silvia
    SAN FRANCISCO, California 94143 (US)
  • SUR, Swastika
    SAN FRANCISCO, California 94143 (US)
  • SIROTA, Marina
    SAN FRANCISCO, California 94143 (US)

(74) Representative: ZBM Patents - Zea, Barlocci & Markvardsen 
Rambla Catalunya, 123
08008 Barcelona
08008 Barcelona (ES)

   


(54) DIAGNOSIS OF ALLOGRAFT ANTIBODY-MEDIATED REJECTION